Passage Bio Inc (NASDAQ:PASG) currently has a daily average trading volume of 193.17K but it saw 726910 shares traded in last market. With a market cap of 16.57M USD, the company’s current market price of $0.27 came falling about -9.63 while comparing to the previous closing price of $0.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.48 and as low as $0.28.
Taking a look at 20-day trading activity of Passage Bio Inc (PASG) gives us an average price of $0.3315, while its current price level is -81.94% below from 52-week high level whereas it is -4.79% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3788 while that of 200 days or SMA-200 reads an average of $0.5933. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.74% during that period while stretching the period over a month that decreases to 14.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 34.50 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wedbush which resumed the stock as “Outperform” in its note to investors issued on November 29, 2024, recommending a price target of between $3 and $4 for it.
Over the week, PASG’s stock price is moving -22.16% down while it is -30.41% when we observe its performance for the past one month. Year-to-date it is -52.99% down and over the past year, the stock is showing a downside performance of -81.86%.
Currently, Passage Bio Inc’s total number of outstanding shares is 62.15M with 0.21% of that held by the insiders while 59.87% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -93.08% and return on equity (ROE) at -83.73%. Stock’s beta reads 1.52. Stock has a price to book (P/B) ratio of 0.35. Its return on asset (ROA) is -56.03% on average.
